Urologic Oncology-seminars And Original Investigations

Urologic Oncology-seminars And Original Investigations

泌尿肿瘤学研讨会和原始研究

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Urologic Oncology-seminars And Original Investigations》是由Elsevier Inc.出版社于1995年创办的英文国际期刊(ISSN: 1078-1439,E-ISSN: 1873-2496),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-泌尿学与肾脏学。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0355...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比91.53%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在295篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Urologic Oncology-seminars And Original Investigations审稿周期约为偏慢,4-8周。该刊近年未被列入国际预警名单,年发文量约295篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 295 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区 4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 179 / 333

46.4

学科:UROLOGY & NEPHROLOGY SCIE Q2 48 / 134

64.6

学科:ONCOLOGY SCIE Q2 147 / 333

56.01

学科:UROLOGY & NEPHROLOGY SCIE Q2 60 / 134

55.6

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 208 / 328

36.7

学科:UROLOGY & NEPHROLOGY SCIE Q2 54 / 133

59.8

学科:ONCOLOGY SCIE Q2 134 / 328

59.3

学科:UROLOGY & NEPHROLOGY SCIE Q2 55 / 133

59.02

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 193 / 322

40.2

学科:UROLOGY & NEPHROLOGY SCIE Q2 46 / 126

63.9

学科:ONCOLOGY SCIE Q2 130 / 322

59.78

学科:UROLOGY & NEPHROLOGY SCIE Q2 48 / 126

62.3

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.6 SJR:0.997 SNIP:0.877
学科类别 分区 排名 百分位
大类:Medicine 小类:Urology Q2 32 / 123

74%

大类:Medicine 小类:Oncology Q2 182 / 428

57%

期刊发文

  • Combined and individual effects of neoadjuvant chemotherapy and lymph node dissection on survival in non-muscle-invasive bladder cancer undergoing radical cystectom

    Author: Sheng, Yiyu; Fan, Longlong; Zhu, Sikun; Wang, Yiran; Zhang, Shiqiang; Xiong, Haiyun

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 5, pp. -. DOI: 10.1016/j.urolonc.2026.111039

  • Comparison of prostate cancer detection rates between micro-ultrasound-guided and multiparametric magnetic resonance imaging-guided prostate biopsy: A systematic review and meta-analysis of prospective studie

    Author: Lu, Yiqiao; Zhao, Dan; Han, Yong; Guo, Yiting; Dong, Yinan

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 5, pp. -. DOI: 10.1016/j.urolonc.2026.111049

  • Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenarian

    Author: Li, Taibo; Bronimann, Stephan; Eraky, Ahmed; Lopez, Carlos Rivera; Cheaib, Joseph; Bignante, Gabriele; Wu, Zhenjie; Wang, Linhui; Simone, Giuseppe; Tuderti, Gabriele; Ferro, Matteo; Decobelli, Ottavio; Sundaram, Chandru P.; Sidhom, Daniel; Yoshida, Takashi; Perdona, Sisto; Tufano, Antonio; Ghodoussipour, Saum; Fu, Melinda; Shah, Ankeet; Ghoreifi, Alireza; Porter, James; Correa, Andres F.; Rais-Bahrami, Soroush; Moon, Sol C.; Derweesh, Ithaar H.; Puri, Dhruv; Meagher, Margaret F.; Minervini, Andrea; Lambertini, Luca; Porpiglia, Francesco; Amparore, Daniele; Checcucci, Enrico; Gonzalgo, Mark L.; Faliknativ, Omri; Margulis, Vitaly; Taylor, Jacob; Cusmano, Nicholas B.; Abdollah, Firas; Veccia, Alessandro; Ditonno, Francesco; Antonelli, Alessandro; Moghaddam, Farshad S.; Djaladat, Hooman; Autorino, Riccardo; Mehrazin, Reza; Singla, Nirmish

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 5, pp. -. DOI: 10.1016/j.urolonc.2026.111041

  • LncRNA NPSR1-AS1 affects the malignant biological behavior of bladder cancer through miR-199a-3p and the clinical value of urine-derived lncRNA NPSR1-AS

    Author: He, Weijing; Wen, Yong; Qin, Huiling

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 4, pp. -. DOI: 10.1016/j.urolonc.2025.12.016

  • Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysi

    Author: Chen, Wei; Yoshida, Soichiro; Yajima, Shugo; Sato, Hiroyuki; Hirakawa, Akihiro; Tanabe, Kenji; Fukushima, Hiroshi; Yasuda, Yosuke; Tanaka, Hajime; Masuda, Hitoshi; Fujii, Yasuhisa

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 4, pp. -. DOI: 10.1016/j.urolonc.2025.110990

  • Efficacy and safety of tislelizumab plus intravesical chemotherapy in recurrent high-risk non-muscle-invasive bladder cancer: A retrospective single-center real-world stud

    Author: Chen, Qing; Wu, Rongpan; Zhang, Chen; Xie, Jiaxin; Wang, Yi; Yu, Xufeng; He, Wei; Wang, Maoyu; Zhao, Junjie; Zhang, Zhensheng; Zeng, Shuxiong; Xu, Chuanliang

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 4, pp. -. DOI: 10.1016/j.urolonc.2025.110988

  • Artificial intelligence-driven prostate cancer diagnosis: Enhancing accuracy and personalizing patient car

    Author: Zhang, Xiaoyi; Xiao, Na; Liang, Hao; Li, Peixin; Zhang, Yaozhong; Zhang, Shijie; Zhou, Bin; Yao, Shengwen; Yang, Zizhuo; Chen, Jun

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 3, pp. -. DOI: 10.1016/j.urolonc.2025.11.013

  • Effect of periurethral structural reinforcement technique on early urinary continence recovery following laparoscopic radical prostatectomy: A retrospective stud

    Author: Ma, Chenxu; Chen, Lili; Li, Yongxiang; Qiao, Liang; Sun, Yadong

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; Vol. 44, Issue 3, pp. 110976-110983. DOI: 10.1016/j.urolonc.2025.12.012